MedTrace Logo

Imaging Dopamine Function and Its Impact on Outcome After Traumatic Brain Injury (TBI)

NCT01850290 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2018-02-05

No results posted yet for this study

Summary

This study will examine resting dopamine function as well as dopamine response in the brain as it interacts with medicines normally prescribed to subacute Traumatic Brain Injury (TBI) patients.

Conditions

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    collaborator OTHER

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Shahid Shafi, MD · Baylor Research Institute

  • Devous Michael, PhD · University of Texas Southwestern Medical Center

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01850290 on ClinicalTrials.gov